Prevalence and Risk Factors of Sleep Disturbance in a Large HIV-Infected Adult Population by Allavena, C., Guimard, T., Billaud, E., De la Tullaye, S., Reliquet, V., Pineau, S., Hüe, H., Supiot, C., Chennebault, J.-M., Michau, C., Hitoto, H., Vatan, R., Raffi, F.

Get full text

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adults by Clumeck, N, Pozniak, A, Raffi, F

Get full text

Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohort by Cuzin, L, Cotte, L, Delpierre, C, Allavena, C, Valantin, M-A, Rey, D, Delobel, P, Pugliese, P, Raffi, F, Cabié, A

Get full text

Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatments by Khatchatourian, L, Le Bourgeois, A, Asseray, N, Biron, C, Lefebvre, M, Navas, D, Grégoire, M, Gaborit, B, Raffi, F, Boutoille, D

Get full text

High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs by Allavena, C, Delpierre, C, Cuzin, L, Rey, D, Viget, N, Bernard, J, Guillot, P, Duvivier, C, Billaud, E, Raffi, F

Get full text

Antiretroviral treatment French guidelines 2013: economics influencing science by Raffi, F, Reynes, J

Get full text

Switching regimens in virologically suppressed HIV‐1‐infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)‐containing regimens by Raffi, F, Esser, S, Nunnari, G, Pérez‐Valero, I, Waters, L

Get full text

Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population by Savès, Marianne, Chêne, Geneviève, Ducimetière, Pierre, Leport, Catherine, Le Moal, Gwenaël, Amouyel, Philippe, Arveiler, Dominique, Ruidavets, Jean-Bernard, Reynes, Jacques, Bingham, Annie, Raffi, François

Get full text

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/μL in the Post—Combination Antiretroviral Therapy Era by Mocroft, A., Furrer, H. J., Miro, J. M., Reiss, P., Mussini, C., Kirk, O., Abgrall, S., Ayayi, S., Bartmeyer, B., Braun, D., Castagna, A., Monforte, A. d'Arminio, Gazzard, B., Gutierrez, F., Hurtado, I., Jansen, K., Meyer, L., Muñoz, P., Obel, N., Soler-Palacin, P., Papadopoulos, A., Raffi, F., Ramos, J. T., Rockstroh, J. K., Salmon, D., Torti, C., Warszawski, J., de Wit, S., Zangerle, R., Fabre-Colin, C., Kjaer, J., Chene, G., Grarup, J., Lundgren, J. D.

Get full text

Influence of HLA‐C environment on the spontaneous clearance of hepatitis C in European HIV–HCV co‐infected individuals by Legrand, N., David, G., Rodallec, A., Gaultier, A., Salmon, D., Cesbron, A., Wittkop, L., Raffi, F., Gendzekhadze, K., Retière, C., Allavena, C., Gagne, K.

Get full text

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN... by van Leth, F, Phanuphak, P, Ruxrungtham, K, Baraldi, E, Miller, S, Gazzard, B, Cahn, P, Lalloo, UG, van der Westhuizen, IP, Malan, DR, Johnson, MA, Santos, BR, Mulcahy, F, Wood, R, Levi, GC, Reboredo, G, Squires, K, Cassetti, I, Petit, D, Raffi, F, Katlama, C, Murphy, RL, Horban, A, Dam, JP, Hassink, E, van Leeuwen, R, Robinson, P, Wit, FW, Lange, JMA

Get full text

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination by Lambert-Niclot, S, Allavena, C, Grude, M, Flandre, P, Sayon, S, Andre, E, Wirden, M, Rodallec, A, Jovelin, T, Katlama, C, Calvez, V, Raffi, F, Marcelin, A-G

Get full text

Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort by Le Guillou, A., Cabie, A., Delpierre, C., Pugliese, P., Jacomet, C., Hentzien, M., Duvivier, C., Zaegel-Faucher, O., Cotte, L., Raffi, F., Bani-Sadr, F.

Get full text

Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy by Allavena, C., Rodallec, A., Leplat, A., Hall, N., Luco, C., Le Guen, L., Bernaud, C., Bouchez, S., André-Garnier, E., Boutoille, D., Ferré, V., Raffi, F.

Get full text

A liquid chromatography–tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir,... by Martin, J., Deslandes, G., Dailly, E., Renaud, C., Reliquet, V., Raffi, F., Jolliet, P.

Get full text

Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegra... by Palich, Romain, Allavena, Clotilde, Peytavin, Gilles, Soulie, Cathia, Tubiana, Roland, Weiss, Laurence, Montoya Ferrer, Ana, Duvivier, Claudine, Bouchaud, Olivier, Bottero, Julie, Durand, Aurore, Lê, Minh-Patrick, Marcelin, Anne-Geneviève, Dudoit, Yasmine, Assoumou, Lambert, Katlama, Christine

Get full text

Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavire... by Dailly, E., Raffi, F., Jolliet, P.

Get full text

National survey of the current management of endometriomas in women undergoing assisted reproductive treatment by Raffi, F., Shaw, R.W., Amer, S.A.

Get full text

A liquid chromatography–tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma by Grégoire, M., Deslandes, G., Renaud, C., Bouquié, R., Allavena, C., Raffi, F., Jolliet, P., Dailly, E.

Get full text

Determinants of blood telomere length in antiretroviral treatment‐naïve HIV‐positive participants enrolled in the NEAT 001/ANRS 143 clinical trial by Alejos, B, Stella‐Ascariz, N, Montejano, R, Rodriguez‐Centeno, J, Schwimmer, C, Bernardino, JI, Rodes, B, Esser, S, Goujard, C, Sarmento‐Castro, R, De Miguel, R, Esteban‐Cantos, A, Wallet, C, Raffi, F, Arribas, JR

Get full text